Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease

INTRODUCTION: The Alzheimer's Disease Neuroimaging Initiative (ADNI) has accumulated 15 years of clinical, neuroimaging, cognitive, biofluid biomarker and genetic data, and biofluid samples available to researchers, resulting in more than 3500 publications. This review covers studies from 2018...

Descripción completa

Detalles Bibliográficos
Autores principales: Veitch, Dallas P., Weiner, Michael W., Aisen, Paul S., Beckett, Laurel A., DeCarli, Charles, Green, Robert C., Harvey, Danielle, Jack, Clifford R., Jagust, William, Landau, Susan M., Morris, John C., Okonkwo, Ozioma, Perrin, Richard J., Petersen, Ronald C., Rivera‐Mindt, Monica, Saykin, Andrew J., Shaw, Leslie M., Toga, Arthur W., Tosun, Duygu, Trojanowski, John Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158456/
https://www.ncbi.nlm.nih.gov/pubmed/34581485
http://dx.doi.org/10.1002/alz.12422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158456/
https://www.ncbi.nlm.nih.gov/pubmed/34581485
http://dx.doi.org/10.1002/alz.12422

Ejemplares similares